Stroke RSS

Filtered By:
Specialty: Cancer & Oncology
Condition: Bleeding
Drug: Proton Pump Inhibitors PPIs

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

< em > ABCG2 < /em > Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
CONCLUSION: The modified HAS-BLED score, a history of bleeding, concurrent use of PPI, ABCG2 rs3114018, and ABCB1 rs1045642 were significantly associated with the risk of bleeding complications in patients on apixaban and rivaroxaban, after adjusting for other confounders. These findings can be used to develop individualized treatment strategies for patients taking apixaban and rivaroxaban.PMID:37641689 | PMC:PMC10460569 | DOI:10.2147/DDDT.S417096
Source: Cancer Control - August 29, 2023 Category: Cancer & Oncology Authors: Hamin Kim Tae-Jin Song Jeong Yee Dong-Hyeok Kim Junbeom Park Hye Sun Gwak Source Type: research